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INTRODUCTION 
Sleep is a state of transient unconsciousness from which the person can be 
aroused by sensory or other stimuli (1) 
 Till the middle of the 20th century, sleep was thought to be a passive 
process. It was a common belief that our neurons become inactive and undergo a 
dormant phase. But recent studies showed that “during sleep our neurons are 
constantly in a firing state”. 
 
 The role of sleep in balancing the mental and physical wellbeing of the 
individual is just beginning to gain importance as an area of research. Sleep is 
under the control of circadian rhythm. But the normal day-night cycle of human 
sleep is not seen nowadays. This has lead to the development of sleep medicine as 
a separate speciality. 
 
Duration of sleep: 
 The duration of sleep for an individual depends upon the age, gender, 
occupation and various other factors. In general the duration of sleep declines 
with age. Children sleep for longer hours in a day. This helps in the regulation of 
hormonal secretion and thus the adequate growth of the child is ensured. Also 
sleep is necessary for consolidation of memory which is responsible for effective 
learning. 
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AGE GROUP SLEEP DURATION 
Newborns (0–2 months) 12 to 18 hours 
Infants (3–11 months) 14 to 15 hours 
Toddlers (1–3 years) 12 to 14 hours 
Preschoolers (3–5 years) 11 to 13 hours 
School-age children (5–10 years) 10 to 11 hours 
Adolescents (10–17 years) 8.5 to 9.25 hours 
Adults, including elderly 7 to 9 hours 
 
 Also the Rapid eye movement (REM ) sleep duration depends on age-
declining as age advances. Apart from age and other characteristics of an 
individual, emotions, food habits, daily activities, presence of illness and use of 
medications are the factors that decide the pattern and adequacy of sleep so that a 
person feels refreshed after waking up.  
 
 Sleep pattern may be disrupted by chronic illness and disrupted sleep 
pattern may also lead to the development of chronic illness. 
 
Sleep Physiology : 
 The total duration of sleep could be broadly divided into two phases based 
on the electrophysiological parameters. They are REM and Non-Rapid eye 
movement (NREM) sleep. This can be recorded by a instrument called 
Polysomnogram. Polysomnogram is a instrument used to record biophysical 
changes during sleep. 
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 The polysomnographic recordings vary in these two phases. These 
variations are cyclical that repeats every 90 minutes. Thus  in a normal 6 to 8 
hours sleep there occurs about four cycles. 
 
SLEEP CYCLE : 
 Sleep cycle begins with NREM sleep, passes through four stages and ends 
with REM sleep. NREM sleep is otherwise called slow wave sleep and occurs in 
four stages 1 to 4. This cycle gets repeated every 70 to 90 minutes. The proportion 
of time taken for each stage varies according to age. The pattern of sleep is also 
characteristic for each individual. There also occurs brief periods of awakening of 
which the person is not aware (called stage W). 
 
 
 
Figure 1 Stages of sleep cycle 
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 Usually in the early part of night, deep slow wave sleep predominates. The 
first REM sleep may occur nearly after one hour of sleep onset. This interval 
becomes progressively shorter in the later part of night. Generally, about 25% of 
the total sleep period is occupied by REM sleep. As age advances the duration of 
REM and stage 4 sleep decreases. Newborns and infants spend about 50% of their 
sleep time in REM sleep. 
 
EEG pattern during sleep: 
 In 1953, Aserinsky, Dement and Kleitman described the phases of normal 
sleep based on the EEG recordings. The normal recordings of EEG in different 
stages of sleep are as follows. 
Stage of sleep EEG findings 
Wakefulness β-waves : 14-30 Hz 
Stage 1 Alpha rhythm 
Stage 2 Sleep spindles and K-complexes 
Stage 3& 4 Delta waves (slow wave sleep) 
REM High frequency, low amplitude waves,PGO spikes 
 
 Stage 2 sleep is considered to be the deep sleep. Delta waves are found to 
be the result of synchronized oscillations of thalamocortical circuit activity. 
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Figure 2 EEG pattern during sleep 
 
NREM sleep : 
 EEG changes differ in the four stages of NREM sleep according to the 
depth of consciousness which increases as sleep progresses from stage 1 to 4. 
Progressively the EEG waves become slower in frequency and higher in voltage.   
 
 But the thinking in NREM could not be recollected as it is very short and 
rudimentary. Tone of the muscles is preserved and DTR could be elicited. EMG 
activity could be recorded in chin and limbs. 
 
 Autonomic activities in NREM sleep are widely decreased, with 
hypotension, bradycardia and decrease in cellular metabolic activities. Secretion 
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of hormones like Growth Hormone, Cortisol and Prolactin occurs. Also changes 
like increase in serotonin secretion is noted   
 
 Thus the early periods of sleep is predominantly NREM and later period 
shows a REM pattern with dream filled sleep which is comparatively lighter. 
 
REM sleep: 
 This phase of sleep is characterized by rapid movement of eye ball and 
profound atonia of limbs sparing the respiratory muscles. About 50% of our total 
sleep is occupied by stage 2 sleep. Among the remaining half of the sleep duration 
about 20% is REM sleep and other stages constitute 30%. But in infants about 
half the duration is REM sleep. Recently it was proved that EEG findings in REM 
sleep are due to activation of proceruleus area in pons and atonia is due to 
activation of sublaterodorsal area.(Lu et al, 2006). These areas are called “REM 
on” areas and the ventrolateral Periaqueductal gray (PAG) and lateral pontine 
tegmentum are the “REM off” areas. These two areas mutually inhibit each other 
and act as a flip-flop switch which controls smooth transition between REM and 
NREM sleep. This switch is influenced by the balance between cholinergic 
neurons on the on-side and Noradrenergic and serotonergic neurons on the off-
side of the REM sleep.  
 
 EEG shows more active pattern than NREM. Ocular movement artifacts 
are commonly seen. EMG record shows a flaccid pattern. But other activities of 
the body are like as if the person is awake. 
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Sleep Latencies: 
 “Sleep latency is  the time interval from the time of retiring to the time at 
which the person falls asleep”. Normal sleep latency is about 10-20 minutes in an 
otherwise healthy person. “ the interval from falling asleep to occurrence of the 
first REM sleep in a sleeping individual is  REM latency”. It may take about 90-
120 minutes within one cycle.  
 
 Disorders like presenile dementia, sleep apnea  affect these two latencies or 
any one of them. Study of sleep latency gives a clue to diagnose those disorders. 
 
DIABETES MELLITUS: 
 Diabetes is the most commonly occurring non-communicable disease in 
the world.it is one of the oldest diseases known to mankind. though the essential 
feature of diabetes is hyperglycemia, the causes are multifactorial and the disease 
affects almost all the organ systems in the body. So it is actually a syndrome 
resulting from interactions between genetic, environmental and behavioural 
factors. 
 
EPIDEMIOLOGY: 
 The WHO fact sheet for diabetes in the year 2014  states that around 422 
million people are affected with diabetes. The global prevalence has increased 
from 4.7% in 1980 to 8.5% in 2014. WHO predicts that Diabetes will be the 7th 
leading cause of death in the world by 2030. (2) 
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INDIAN STATISTICS: 
 India topped the world with 31.7 million diabetics in the year 2000. It is 
estimated that by 2030 the number of diabetics in India will become 79.4 million. 
The etiology of diabetes in India is again multifactorial with increasing obesity 
being the main cause. The rapid urbarnisation with lifestyle changes in the past 
few decades have contributed for the escalating rates of occurrence of diabetes in 
India. Also obtaining a uniform statistics is difficult due to wide variations in the 
diet and cultural practices across the country.(3) 
 
CLASSIFICATION OF DIABETES: 
 Diabetes is broadly classified as Type 1 and Type 2 diabetes. This 
classification is based on the pathophysiology that leads to hyperglycemia. 
Accordingly the etiological classification of diabetes is as follows. (4) 
 
 
I.Type 1 diabetes (βcell destruction, usually leading to absolute insulin deficiency) 
A. Immune mediated 
B. Idiopathic 
 
II. Type 2 diabetes (may range from predominantly insulin resistance with relative insulin 
deficiency to a predominantly secretory defect with insulin resistance) 
 
III. Other specific types 
A. Genetic defects of βcell function 
B. Genetic defects in insulin action 
C. Diseases of the exocrine pancreas 
D. Endocrinopathies 
E. Drug or chemical induced 
F. Infections 
G. Uncommon forms of immune-mediated diabetes 
H. Other genetic syndromes sometimes associated with diabetes 
 
IV. Gestational diabetes mellitus 
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TYPE 1 DIABETES MELLITUS: (Insulin dependent diabetes mellitus) 
Type 1 diabetes is characterized by hyperglycemia produced due to 
complex disease process that mostly occurs after sudden onset of an auto immune 
process owing to genetic and environmental factors.The pancreatic β cells of the 
islets of langerhans are destroyed during this process resulting in insufficient 
insulin production .Administration of  exogenous insulin remains the main stay of 
treatment. 
 
TYPE 2 DIABETES MELLITUS: 
 Previously  known as non-insulin dependent diabetes or adult onset 
diabetes. Individuals with this disorder have predominantly insulin resistance with 
relative insulin deficiency. This accounts for about 90-95% of the diabetic 
population in the world. 
 
 The stage before the development of overt diabetes is called impaired 
glucose tolerance or prediabetes.The current diagnostic criteria for diagnosis of 
Type 2 Diabetes mellitus is as follows. (5) 
 
 
 
1. Casual plasma glucose ≥ 200 mg/dl plus classical symptoms. 
or 
2. Fasting plasma glucose (FPG) ≥ 126 mg/dl 
or 
3. 2- hr Plasma glucose ≥ 200 mg/dl on 75-gm oral glucose tolerance test 
or 
4. HbA1c ≥ 6.5% using standardised lab method. 
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RISK FACTORS:  
 Type 2 DM is a result of interplay between genetic and metabolic 
factors.Ethinicity, family history of diabetes, unhealthy diet, physical inactivity 
smoking and previous gestational diabetes increase the risk. 
 
 Family history of diabetes (i.e., parent or sibling with type 2 diabetes) 
 Obesity (BMI 25 kg/m2) 
 Physical inactivity 
 Race/ethnicity (e.g., African American, Latino, Native American, Asian 
American, Pacific Islander) 
 Previously identified with IFG, IGT, or an A1C of 5.7–6.4% 
 History of GDM or delivery of baby >4 kg (9 lb) 
 Hypertension (blood pressure 140/90 mmHg) 
 HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride 
level >250 mg/dL (2.82 mmol/L) 
 Polycystic ovary syndrome or acanthosis nigricans 
 History of cardiovascular disease 
 
 Of all the above risk factors Obesity is the often an associated feature or 
the affected individuals atleast have increased percentage of body fat mainly 
deposited around the abdomen. Obesity related complications are frequently 
associated with this type of diabetes. Persons withthis type of diabetes often have 
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comorbidities like hypertension, obstructive sleep apnea etc. and also are more 
likely to develop metabolic syndrome. 
Obstructive sleep apnea(OSA)  is frequently  associated with obesity and as 
obesity is a risk factor for diabetes, persons suffering from OSA tend to develop 
diabetes mellitus. 
 
COMPLICATIONS OF DIABETES: 
 Diabetic ketoacidosis and Non-ketotic Hyperosmolar coma are the acute 
complications of Type 1 and Type 2 DM respectively. These two conditions are 
treated as emergencies in diabetes. 
 
 Since the basic pathology is Hyperglycemia Diabetes Mellitus has impact 
on almost all organs and systems of the body.the incidence of complications 
increase with chronicity of the disease. Sometimes the complications may be the 
presenting feature that leads to a diagnosis of diabetes. 
 
 Complications can be considered in two broad groups – vascular and non-
vascular compilcations. Vascular complications may be due to microvascular 
events or macrovascular events. The commonest chronic complications of 
Diabetes mellitus are listed below. 
  
12 
 
 
 
Microvascular 
1. Eye disease 
                    Retinopathy (nonproliferative / proliferative) 
                    Macular edema 
2. Neuropathy 
                    Sensory and motor (mono- and polyneuropathy) 
                    Autonomic 
3. Nephropathy 
Macrovascular 
1. Coronary heart disease 
2. Peripheral arterial disease 
3. Cerebrovascular disease 
Other 
1. Gastrointestinal (gastroparesis, diarrhea) 
2. Genitourinary (Infections/sexual dysfunction) 
3. Dermatologic 
4. Infectious 
5. Cataracts 
6. Glaucoma 
7. Periodontal disease 
8. Hearing loss 
 
  
13 
 
 
 
Glycated Hemoglobin:(6) 
 These are minor variant of adult hemoglobin (HbA) to which glucose is 
attached to the N-terminal valine residue of the β-chain. By chromatographic 
techniques this group of molecules can be seperated into HbA1a(1.6%), 
HbA1b(0.8%) and HbA1c(3-6%). Since the concentration of HbA1c forms the 
major share, measurement of this fraction is considered as the total measure of 
glycated hemoglobin. 
 
 Conversion of HbA to HbA1c is possible throughout the lifespan of RBC. 
So its concentration is higher in older RBCs and the rate of conversion is greater 
in diabetics as the plasma glucose levels are higher. So measurement of HbA1c 
can be used to diagnose DM. 
 
 Also the life span of HbA1c is longer and so the levels of glycated 
hemoglobin reflect the blood sugar levels over a period of  12 weeks. Thus 
HbA1c measurement is a  good parameter  to assess diabetic control over the 
previous 4-6 weeks. And these measurements correlate with the complications of 
diabetes mellitus also. (7) 
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Methods to study normal sleep: 
 Sleep could be either studied by clinical observation or by recording the 
physiological information using the instruments. 
 
 The instrumental recording of the physiological changes during sleep could 
be done by recording a polysomnography. 
 
 Polysomnography as a term was coined in 1974 by Holland, Dement and 
Raynall as this method employs recording of of Electro encephalogram (EEG), 
Electro oculogram (EOG),Electromyogram (EMG), Electrocardiogram (EKG), 
vital signs and breathing parameters. 
 
 Polysomnography is actually a technique of comprehensive recording of 
biophysiological changes during sleep along with the analysis and interpretation 
of results. Standardised scoring manual are available with universally uniform 
terminology and specifications. A.Rechtschaffen and A.Kales in 1968 were the 
first persons to bring out a manual for sleep study and its interpretation (popularly 
known as R & K criteria).(8) 
 
 American Academy of Sleep Medicine (AASM) incorporated 
comprehensive rules for scoring and terminologies for interpretation in 2007.(9) 
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The AASM terminologies are as follows. 
1. N denotes NREM sleep 
2. R denotes REM sleep 
3. N1 and N2 are stage 1 and stage 2 
4. N3 is sum of stage 3 and stage 4 
5. The post auricular placement of electrodes are called M1 and M2 instead of 
A1 and A2. 
 
 Clinical polysomnography classically records the EEG during sleep with 
the help of the electrodes placed on the scalp according to the standardized 
international 10-20 system.(10) 
 
In addition to this others parameters that are recorded are  
1. EMG in the anterior tibialis muscle  
2. Plethysmography to record respiratory effort 
3. Nasal and oral airflow 
4. Pulseoximetry to measure oxygen saturation 
5. EOG to record the eye movements 
6. Audiovisual means are used to record the gross body movements 
7. ECG 
 
 Recording is done in a thermal paper like ECG. This paper length is 
divided into segments of time for convenient reporting. Each segment is called an 
EPOCH. The paper speed for recording is 10 mm/s and a 30 cm page represents 
30 secs recording. This forms an epoch. Even after digitalization of the 
polysomnogram scoring is done conventionally using a 30 sec epoch window.  
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Recording system includes : 
 Quality amplifier 
 Filter design and configuration 
 Independent filter selections for each channel 
 Adequate sampling rates and bit resolution for each recorded parameter 
 Input signal referencing capabilities 
 Provisions for standard calibration procedures and signal verification 
 Appropriate signal display 
 
 Analog type instrument or a digital instrument can be used for recording. 
The digital recorders need computers for data analysis. Advantage of digital 
instruments is that data could be store for future retrival. A  typical device may 
PREREQUISITES FOR CONDUCTING POLYSOMNOGRAPHY 
 
Air conditioned room with attached bathroom 
Polysomnographic recording system 
Computer 
Amplifiers 
Electrodes and application material 
Pulse oximeter-to detect blood gas analysis 
Abdominal and thoracic belts-to detect respiratory effort 
Nasal airway pressure transducer- to detect nasal airflow 
Access to emergency medical care 
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store upto 50 megabytes of data for an 8 hour recording. This data could be 
downloaded to a computer and analysed using appropriate software. 
 
Sources of signal 
Three signalsources in polysomnography are: 
1.  Bio electric potentials like EEG, EOG, EMG, ECG 
2. Trasnduced signals from the sensors attached to the patient like 
plethysmography, body position sensors etc. 
3. Ancillary equipment signals like pulseoximeter.  
 
 All the above mentioned instruments are provided with their own processor 
circuits, display and output. 
 
Amplifiers : 
 A direct amplifier records slowly changing potentials as from a pulse 
oximeter. The alternating current amplifier records high frequency potentials as 
from the EEG, EOG etc. A differential amplifier  amplifies the difference between 
electrode inputs instead of  the absolute voltage at any electrode. The 
contamination from the electrical noise is prevented by subtracting it out. This 
ability of the amplifier to suppress an unwanted signal  is called common 
moderejection. 
 
FILTERS: 
 Use of filters helps to remove the unwanted signals that escape the 
differential amplifier. 
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Filters are of different  types: 
 High frequency filter (HFF)- attenuates the higher frequency amplitude 
signals above the cut off value and thus determines the highest frequency 
that a channel would display.  
 
 Low frequency filter (LFF)-attenuates the lower frequency signals below 
the cut off value and thus determines the lowest frequency that a channel 
would display. 
 
 Notch filter – eliminates 50 or 60 Hz frequency interference from amplifier 
output. 
 
 Digital filter –deltes selected frequencies after digital conversion of the 
amplified signals using software algorithms. 
 
DIGITAL SPECIFICATION FOR ROUTINE 
POLYSOMNOGRAPHY (AASM GUIDELINES) 
Electrode 
Desirable 
sample 
rate(Hz)  
Minimal 
sampling 
rate (Hz) 
High 
frequency 
filter (Hz) 
Low 
frequency 
filter (Hz) 
Maximum 
impedance 
(K Ohms) 
EEG 500 200 35 0.3 5 
EOG 500 200 35 0.3 5 
EMG 500 200 100 10  
EKG 500 200 70 0.3  
Snoring 500 200 100 10  
Airflow 100 25    
Oximetry 25 10    
Chest and 
abdominal 
movement 
100 25    
Body 
position 
1 
 1    
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MEASUREMENT OF SIGNALS: 
Signals recorded are measured according to  
1. Frequency- the number of waves appearing per second that is cycles per 
second or Hertz 
2. Amplitude – Amplitude is the measure of the electrical voltage. Vertical 
height of a wave represents the amplitude.  
 
 This independent on the sensitivity setting of the amplifier .Sensitivity is 
the voltage needed to produce a set deflection of the pen. It is inversely 
proportional to the amplitude. 
 
 
Figure 3 Leads of Polysomnography 
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Thus the actual process by which the electrical signals from the patient are 
converted to digital data is as follows. 
 
  
Review of literature 
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REVIEW OF LITERATURE 
 
Sleep – a necessity for survival. 
 “Why animals and humans sleep?” is a still unanswered question. However 
our performance during wakefulness, physical and mental health is highly 
dependent on the quality of our sleep. Brain development may be related to the 
sleep pattern. This may be explained by longer duration of deep sleep among 
infants.(11) 
 
Functions of sleep: 
 Again the functions of sleep is also a query for which the answers are being 
still formulated. But all animal species sleep and so sleep can be regarded as rest 
period for the organ systems that were continuously working during wakefukness. 
Cessation or reduction of the metabolic activity during sleep serves this purpose. 
The brain is the most benefitted organ during sleep. This particular organ 
replenishes its energy stores during sleep.so the most important  function of sleep 
is brain restitution. Sleep plays a role in learning and consolidation of memory.(1) 
 
Physiological changes during sleep: 
 During sleep the physiological activities of the organ systems vary from 
that of during wakefulness. There is increased parasympathetic tone with reduced 
sympathetic activity. As a result the heart rate, blood pressure and respiratory rate 
are lower during sleep. Due to muscle relaxation the upper airway resistance 
increases particularly in REM sleep. Body temperature is lower than normal 
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especially during slow wave sleep. Sleep also has a important role in regulation of 
hormone secretion.(12) 
 
Sleep deprivation: 
 The condition when an individual does not get adequate sleep is called 
sleep deprivation.this may be due to organic sleep disorders per se or may be a 
behavioural disorder. 
 
 When an individual does not go bed according to their biological clock and 
continue to be in the wakeful state than for an expected duration it is called  total 
sleep deprivation. This will be usually followed by compensatory sleep that 
restores the normal sleep cycle.  
 
 Partial sleep deprivation is when an individual goes to bed but the quality 
and quantity of sleep is not optimum. This partial deprivation of sleep can occur 
in three ways. One is fragmentation of sleep (eg. Obstructive sleep apnea). This 
condition is characterised by disrupted progression in the sequence of  stages of 
sleep. Second type of partial sleep deprivation is loss of specific stages of sleep 
and can be denoted as selective sleep deprivation. Third type sleep restriction 
which is typically reduced duration of sleep.(13,14) 
 
Effects of sleep deprivation: 
 Brain is the primary organ that is highly dependent on sleep for its normal 
functioning than other organ systems. The immediate effect of  both acute and 
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chronic sleep deprivation is cognitive impairment. Apart from this sleep 
deprivation also causes mood changes and  neuroendocrine changes.(15) 
 
 As a result of these changes the metabolic processes of the body are also 
altered when the individual suffers sleep deprivation particularly of the partial 
type. Many physiological indices are altered due to short term sleep restriction. 
Some of them are increase in BP, (16) sympathetic nervous system activation(17), 
decreased levels of leptin(18), high production of inflammatory markers.(19) 
 
 Numerous endocrine metabolic changes are also seen after sleep 
deprivation or sleep restriction. Some of these effects are increase in serum 
cortisol levels in an evening sample, decreased thyrotropin activity and above all 
the most important is the impaired glucose tolerance. (20) 
 
This impaired glucose tolerance is the preliminary stage of diabetes mellitus. 
 
SLEEP and DIABETES: 
 Behavioural sleep restriction has become a necessity nowadays due to 
globalization, lifestyle changes and work pattern modifications.Currently there are 
authenticated evidences that behavioural sleep restriction has increased the 
incidence of obesity and diabetes. Three mechanisms are proposed for the 
development of obesity and diabetes in sleep deprived individuals. 1. alterations 
in glucose metabolism; 2. upregulation of appetite; 3. decreased energy 
expenditure.(21) 
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Sleep and Glucose metabolism: 
 As the overall metabolic rate decreases during sleep so does the glucose 
metabolism. In the first half of night the metabolism of glucose is slower due to 
predominance of slow wave sleep which is associated with lowered cerebral 
glucose uptake and reduced peripheral glucose utilisation. These effects are 
reveresed in the second half of the night which is characterised by increase in 
frequency of REM sleep.(22,23) 
 
 Glucose tolerance is the ability of the body to secrete insulin according to 
the plasma glucose levels so as to activate the glucose metabolism and return 
blood glucose to normoglycemic levels. this is highly dependent upon the 
pancreatic beta cell function to secrete required quantities of insulin and the 
ability of the insulin to adequately metabolise the blood glucose. Reduced Insulin 
sensitivity or insulin resistance is a condition which denotes the requirement of 
larger amount of insulin to bring back the normoglycemic states when there is 
altered levels of blood glucose. This glucose tolerance is at its minimum during 
the night than in the morning and so insulin resistance is higher in the night. (24) 
 
Sleep and appetite: 
 Food intake is normally regulated by two different neuronal areas in 
hypothalamus – the appetite stimulating and appetite suppressing areas. These two 
areas are influenced by two peripheral signals the leptin and ghrelin. Leptin 
promotes satiety and decreases food intake while ghrelin induces hunger and 
increases food intake.(25,26,27) 
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 During  normal conditions there is a nocturnal rise of plasma leptin and 
ghrelin levels . the ghrelin levels come down in the later part of night and so the 
appetite is suppressed during normal sleep. Sleep deprivation in rodents have 
resulted in hyperphagia. 
 
 This is because of the action of another hormonal substance called orexin. 
Orexin acts upon the lateral hypothalamus and stimulates the secretion of 
neuropeptide Y which increases the food intake. Orexin also influences certain 
neuronal areas that maintain wakefulness. Thus by maintaining wakefulness 
orexin promotes eating behavior also.(28) 
 
 There is evidence of irregular eating habits, in between meal snacking, 
execessive seasoning of food and less intake of vegetables associated with sleep 
deprivation.(29) 
 
 A previous study conducted on 12 healthy volunteers with 2 days of sleep 
restriction and 2 days of sleep extension under controlled intake of calories and 
physical activity showed significant increase in  hunger and food intake especially 
of high calorie value with significant increase in ghrelin levels and decrease in 
leptin levels. (30) 
 
 One another study examined the changes in energy intake and energy 
expenditure along with leptin and ghrelin levels with respect to normal and 
restricted sleep duration. Eleven healthy volunteers participated in this study in an 
inpatient basis and sleep was recorded using a polysomnography consisting of  
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EEG, EOG and EMG. The results showed significant increase in consumption of 
snacks and carbohydrate rich food during restriction of sleeping hours with no 
significant changes in serum leptin and ghrelin levels (31). Thus sleep deprivation 
causes increase in energy intake and decrease in energy expenditure which may 
lead to obesity – an important predisposing factor for diabetes. 
 
Sleep and energy expenditure: 
 Energy expenditure plays a major role in controlling increase in body 
weight and development of obesity. Total energy expenditure (TEE) of the body 
depends upon the resting basal metabolic rate(RMR), thermogenic effect of meals 
(TEM) and activity related energy expenditure(AEE). In most persons this AEE is 
determined by the non-exercise activity thermogenesis (NEAT) which is the 
energy loss during normal physical activities ike sitting, standing, walking etc.(32) 
Weight loss and prevention of obesity depends upon the AEE and NEAT. Obese 
individuals have lower levels of NEAT than non obese individuals.(33) Subjects 
with sleep disorders both organic and behavioural report execessive daytime 
sleepiness and reduced physical activity which in turn would reduce the AEE. 
Thus contributing to increase in weight gain.(34)  
 
 All the above discussions point that sleep deprivation through various 
mechanisms as summarised in the figure below leads to development of diabetes.  
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Fig 4 Mechanism of Sleep deprivation  for Diabetes 
 
Sleep disorders and diabetes: 
 So far we have discussed about the effect of behavioural sleep restriction 
on diabetes.also organic sleep disorders may also lead to the development of 
diabetes. The sleep disorders are classsified into seven broad categories according 
to the international classification of sleep disorders (ICSD 3) (35) As follows. 
 
1. insomnia disorders 
2. sleep-related breathing disorders 
3. central disorders of hypersomnolence 
4.  circadian rhythm sleep-wake disorders 
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5. sleep-related movement disorders 
6. parasomnias 
7. other sleep disorders. 
 
 These sleep disorders when not adequately treated,through various 
mechanisms lead to the development of diabetes as outlined in the following 
figure. 
 
 
 
Figure 5 Mechanism of Sleep depreviation causes Glucose intolerance 
 
 When the effects of sleep deprivation on HPA axis were studied in three 
groups of subjects- one with normal sleep, second with partial sleep deprivation 
and the third with total sleep deprivation the cortisol levels were measured during 
the evening following sleep deprivation were higher in both the sleep deprived 
groups in comparison to that measured during the previous day. In the normal 
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sleepers there is no such increase.(36) this sleep deprivation induced HPA axis 
hyperactivity is involved in metabolic consequences like obesity, diabetes etc.(37) 
The circadian rhythmicity also plays a great role in metabolic processes 
particularly glucose homeostasis. Nutrition has been identified as a potential 
zeitgeber(38). In animal models melatonin and melatonin receptor agonist 
administration influence the glucose homeostasis in various ways like increase in 
glucose uptake by the tissues, increase in glucose induced insulin secretion, better 
insulin sensitivity and lower rates of gluconeogenesis (39). 
 
 Also melatonin increase glycogen synthesis in liver(40), limits fat 
accumulation and adiposity in humans(41), thus preventing obesity. So distruption 
of the circadian rhythm due to various conditions like shift work, repeated travel 
across time zones may result in metabolic derangements in glucose homeostasis. 
Both cross-sectional and retrospective studies on shift workers show an increased 
incidence of type 2 diabetes mellitus(42), glucose intolerance(43), insulin 
resistance(44) and metabolic syndrome (45). 
 
 Obstructive Sleep Apnoea (OSA)is a common sleep disorder which is 
increasing in prevalance with the increase in obesity. (46)  
 
 OSA is characterised by intermittent hypoxia and frequent arousals thus 
causing disrupted sleep pattern. OSA being an independent risk factor for 
cardiovascular disease is also implicated as a causative factor in various metabolic 
derangements like dyslipidemia, insulin resistance, glucose intolerance and type 2 
diabetes mellitus.(47,48) OSA causes intermittent hypoxia which is implicated as a 
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cause for these metabolic derangements evidenced by presence of insulin 
resistance even in non- obese OSA patients. (49) 
 
 As outlined in the figure below intermittent hypoxia acts on different 
insulin sensitive tissues and organs by various mechanisms and leads to 
development of diabetes.(50) 
 
Figure 6 Mechanism of intermittent hypoxia causes insulin resistance 
 
 Intermittent hypoxia causes sympathetic activation and thus elevated levels 
of circulating of catecholamines.(51,52). The epinephrine released during 
sympathetic activation causes a trigger in glucose production and impairment in 
insulin secretion resulting in insulin resistance.(53) 
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 Another hallmark finding in OSA is sleep fragmentation, a condition where 
total sleep duration is not altered but there is discontinous sleep with altered 
architecture. Experimental studies inducing sleep fragmentation with auditory and 
mechanical stimuli showed a decrease in insulin sensitivity which is not 
compensated by increase in insulin secretion suggesting that sleep fragmentation 
alters glucose homeostasis(54,55). Also as evidenced by wrist actigraphy the type 2 
diabetes patients manifest sleep fragmentation.(56)  the actigraphy performed on 
diabetics showing sleep fragmentation is associated with higher fasting blood 
glucose when compared with non diabetics.(57) 
 
Sleep and glycemic control: 
 There are evidences to show that sleep deprivation may cause increased 
risk for developing diabetes. Sleep deprivation also causes some adverse changes 
in existing diabetic status. A survey study done on 161 type 2 diabetes patients 
concluded with a predicted increase of HbA1c for a 3 hour sleep debt per night as 
1.1% above the median and 1.9% above the median for a 5 point increase in  
Pittsburgh sleep quality index  ( PSQI )scores.(49) 
 
 A previous study conducted on 118 subjects with type 2 diabetes found that 
sleep duration and segments of short naps significantly predicted the HbA1c 
levels. There was a reduction of HbA1c by 0.174% with an increase in duration of 
sleep by onehour. So authors have concluded that increasing the duration of sleep 
and short naps inbetween improves the glycemic control.(50) 
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 In another study conducted on geriatric diabetic patients the was a 
relationship between sleep quality and glycemic control when the reference value 
of HbA1c was fixed at 7% there was approximately a four fold increase in HbA1c 
levels when there was an increase in  Epworth sleepiness scale  (ESS) scores.(51) 
 
 A cross sectional study conducted on 1022 japanese healthy adults in the 
age group of 22-69 yrs. showed a significant  positive linear correlation of high 
HbA1c with insomnia symptoms like difficulty in maintaining sleep and early 
morning awakening.(52) 
 
 In one another previous study 46 type 2 diabetes patients were investigated 
for glycemic control with HbA1c and quality of sleep assessed using PSQI. After 
adjusting for age, gender and BMI the PSQI scores significantly correlated with 
HbA1c in the positive direction. (53) 
 
 Quality of life in diabetic patients was assessed with quality of life index 
questionnaire and quality of sleep using PSQI. Quality of life in diabetics was 
dependent upon the quality of sleep. In turn the sleep duration positively 
correlated to HbA1c levels and fasting blood glucose. HbA1c negatively 
correlated with PSQI scores suggesting that lower HbA1c is associated with good 
sleep quality.(54) 
 
 Evidences are present for elevated HbA1c in diabetic patients engaged in 
shift work and the insufficient glycemic control was linked to the duration of 
hours of shift work and duration of employment in the shift work.(54,55) 
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 In a previous study of  polysomnography on 60 type 2 diabetes patients 
about 77%  of them had OSA and the severity of OSA was significantly 
associated with poor glycemic control as evidenced by increased levels of 
HbA1c.(56) 
 
How diabetes affects sleep: 
 Sleep and diabetes has a bidirectional relationship. Poor sleep quality leads 
to diabetes and presence of a diabetic state leads to poor quality of sleep. The 
proposed mechanisms for poor sleep quality in diabetes can be summarized in the 
following figure. 
 
 
Fig 7 Mechanism of Diabetes for poor quality of sleep 
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 Nocturia is waking up in the night to void.Nocturia causes sleep 
disturbance by frequent awakening thus affecting both onset and maintenance of 
sleep (57). Polyuria a feature of diabetes can lead to nocturia through distension of 
bladder beyond its capacity or through solute diuresis. Another mechanism 
involved is diabetic patients with associated OSA is the stretching of myocardium 
due to the negative intrathoracic pressure resulting in release of Atrial Natriuretic 
Peptide that causes excess sodium and water excretion (58). In a previous study 
done on 74 type 2 DM patients nocturia was found to be associated with sleep 
maintenance difficulties thus reflecting poor quality of sleep (59).  
 
 Another cause for sleep disturbance in diabetes may be nocturnal 
hypoglycemia. This is more consistent with type 1 diabetes where hypoglycemic 
episodes are frequent. Studies have shown that most of the hypoglycemic episodes 
occur at night (60). 
 
 Restless Leg Syndrome (RLS) is a sensorimotor disorder characterised by 
an irresistible urge to move the legs that is aggravated by rest and relieved by 
movement, the symptoms classically worsen at night (61). Evidences show that 
there is increased risk of RLS in diabetic patients (62).  Type 2 DM patients with 
co-morbid RLS report poor sleep quality and efficiency characterised by 
prolonged sleep latency resulting in more daytime dysfunction than diabetics 
without RLS(63). 
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 Obstructive sleep apnea (OSA) is one of the sleep disordered breathing. 
This leades to apneic episodes causing intermittent hypoxia, frequent arousals 
causing sleep fragmentation, reduction in Total Sleep Time (TST) causing 
daytime sleepiness.(64) the intermittent hypoxia in OSA patients has been 
investigated as a chief cause of insulin resistance through increase in sympathetic 
activation and serum cortisol levels.(65) 
 
In a polysomnographic study conducted on 306 type 2 diabetes patients 
about 86% of the participants had OSA with approximately 22% had severe OSA 
and 30% had moderate OSA(66). 
 
 Another study on diabetic patients with poor glycemic control with HbA1c 
≥ 7% revealed a prevalence of 37.2% for OSA among this group(67) 
 
 Diabetic patients both type 1 and type 2 have increased risk of 
cardiovascular problems particularly congestive cardiac failure(68,69). These 
diabetic patients with co morbid heart disease also have disturbed sleep due to 
various reasons like  dyspnea,orthopnea, paroxysmal nocturnal dyspnea,OSA, 
pain, medication effects etc(70). 
 
 A review article published in 2012 states that there is a close relation 
between sleep, aging and meatbolic syndrome. Diabetes being one of the 
components of metabolic syndrome is closely associated with sleep disorders and 
sleep disorders in turn lead to early development of diabetes and poor glycemic 
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control in existing diabetes. The relation between diabetes and sleep could be 
expalined by the following flow chart(71). 
 
 
Fig 8 . The relation between diabetes mellitus and sleep 
  
Aim and objectives 
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AIM AND OBJECTIVE OF THE STUDY 
 
 The primary aim of the study is to  investigate the sleep pattern in type2 
diabetes mellitus patients in relation to their HbA1c.  
 
OBJECTIVES : 
1. To assess the polysomnographic parameters in type 2 diabetes mellitus 
patients 
2. To  assess the sleep pattern relation with HbA1c level. 
3. To  assess the sleep pattern relation with duration of Type 2 diabetes 
mellitus. 
4. To assess subjective daytime sleepiness using Epworth Sleepiness Scale in 
type 2 diabetes mellitus patients 
5. To assess the quality of sleep using Pittsburgh Sleep Quality Index in type 
2 diabetes mellitus patients 
 
  
Materials and methods 
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MATERIALS AND METHODS 
 
 The  place of the study was  the Institute of Physiology and Experimental 
Medicine, Madras Medical College. The study duration was May 2016-April 
2017. Approval to conduct the study was obtained from the Institutional Ethics 
Committee (IEC), Madras Medical College, Chennai. 
 
 Subjects for the study group were recruited from the Institute of 
Diabetology, RGGGH, Chennai. 
 
Subject selection: 
 Study population consists of  30 patients of both genders in the age group 
of 40-60yrs diagnosed with and undergoing treatment for Type 2 diabetes 
mellitus. 
 
 Thirty subjects matched for age and gender with normal blood sugar levels 
and HbA1c levels were taken as controls. 
 
Inclusion criteria: 
 Patients diagnosed with and on treatment for Type 2 Diabetes of any 
duration, both  men and women in the age group of 40 – 60 years were included in 
the study. 
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Exclusion criteria: 
Subjects with the following conditions were excluded from the study. 
 Type 1 diabetes mellitus 
 Patients regularly taking sleep medications 
 Psychiatric illness 
 Obstructive sleep disorder 
 Pregnancy and post-partum period 
 Patients with secondary infections 
 Neoplastic, hepatic,  respiratory and any cardiovascular disorders 
 Other concurrent medical illness like renal failure, cardiac failure etc. 
 Subjects taking medications that influence sleep pattern 
 
 According to the above inclusion and exclusion criteria subjects were 
recruited for  the study after obtaining informed consent both in the verbal and 
written form. 
 
Study design: Cross sectional study 
 
Methodology : 
 After  obtaining informed consent, the participants of the study  were 
subjected to the following investigations. 
 
 Blood glucose levels- fasting and postprandial with Glycated Hemoglobin. 
 Polysomnography. 
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Sample collection 
 Under universal precautions 5 ml of venous blood sample was taken in the 
fasting state. 
 
 The sample is centrifuged at 3000 rpm for 10 secs and serum separated and 
stored in the deep freezer at -20°C. The samples were sent to the central 
laboratory at RGGGH under the Institute of Biochemistry and analysed for FBS, 
and HbA1c. 
 
After  2 hours post prandial sample was also collected in the same manner for 
estimation of PPBS. 
 
 
Storage of FBS, PPBS samples 
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Estimation of FBS and PPBS 
 FBS and PPBS was measured in the unhemolytic serum samples by 
Trinder’s method using the principle of oxidation of glucose to gluconic acid and 
hydrogen peroxide. A peroxidase enzyme generates a coloured quinonemine 
complex whose absorbance is proportional to the concentration of glucose in the 
sample. 
 
 The values were analysed according to the diagnostic criteria. 
 
 Subjects with FBS < 126 mg/dl and PPBS<200 mg/dl were considered as 
non- diabetics. 
 
 Those with FBS>126 mg/dl and PPBS> 200 mg/dl were included in the 
study group. 
 
Estimation of HbA1c 
 Glycated hemoglobin was measured in a whole blood sample by particle 
enhanced immuno turbidimetric method  using mouse and goat IgG monoclonal 
antibody. In this method HbA1c can be measured without measuring the total 
hemoglobin. 
 
Values were interpreted as follows. 
 Subjects with <6.5% were included in the non diabetic group. 
 Subjects with >6.5% were included in the study group. 
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Storage of HbA1c samples 
 
Polysomnography 
 Digital polysomnography was done for the consented persons using the 
MEDICAID SC32 in the human experiments laboratory  of Institute of 
Physiology and Experimental medicine. A battery of noninvasive tests were done 
and the parameters measured are 
 Electroencephalogram (C4/A1, C3/A2) 
 Electro-oculograms (right & left) 
 Submental and leg myogram 
 Electrocardiogram 
 Thoracic and abdominal movements 
 Oxyhemoglobin saturation 
 Nasal airflow 
 Sleep position 
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 Sleep efficiency (percent of time in bed spent asleep;SE) 
 Sleep latency (time from lights out to the ®rst epoch of any stage of sleep) 
 Percent of total sleep time of stages 1, 2, 3 and 4, REM sleep 
 Slow wave sleep (SWS) 
 
 Prior to the procedure participant was given  a detailed information about 
the purpose and procedure of polysomnography. He/she was made aware that they 
will be monitored throughout their sleep and educated about when and how to 
contact the technologist. 
 
 A complete medical history including a detailed sleep history was recorded 
and a comprehensive clinical examination was done to record the basic vital 
parameters. 
 
 A convenient date was fixed for recording. 
 
 Then the participant was given the following set of instructions to be 
followed on the day of reporting. 
 To have an evening bath and a clean facial shave. 
 avoid applying oil to any part of the body 
 To dine at least an hour before the procedure 
 avoid alcohol on the day of procedure 
 not to take coffee or tea at least 3 hours prior to procedure 
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 Report with their  routine sleep wear 
 Remove all ornaments 
 To bring all previous medical reports 
 Report  at the appointed time 
 
Patient tray was kept ready with the following things. 
 EEG paste 
 Measuring tape 
 Cotton swabs 
 Electrodes, sensors, and lead wires 
 Spirit 
 Micropore 
 Gloves 
 Scissors 
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Polysomnogram with Head box 
  
 
Procedure: 
 The procedure starts with Patient Hookup. It is nothing but the systematic 
placing of various surface electrodes and sensors on the patient’s body. 
 
Electroencephalogram:  
 EEG is the recording of the electrical activity of neurons using surface 
electrodes. The pyramidal cells of the cerebral cortex generate EPSP and IPSP. 
These potentials are recorded through the scalp using the principle of 
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conductivity. It is noninvasive and the high temporal resolution enables even 
subtle changes of few milliseconds to be effectively detected. But due to low 
spatial resolution it requires a large group of neurons to discharge synchronously. 
 
 Artifacts like movements of eye, head and muscle, electrical signals from 
surroundings could contaminate the EEG record and this should be eliminated 
while making the interpretation. EEG recording is done using eight electrodes-six 
“ exploring ” and two “reference” electrodes. The amplitude of the wave forms is 
dependent on the distance between the two recording electrodes. In order to 
maximize the inter electrode distance C3 or C4 electrodes used as reference 
electrode in relation to the opposite mastoid. Always recording is done through 
two channels so that one can be used as a backup record. 
 
 The electrodes used are cup electrodes plated with gold or silver chloride. 
 
According to the R & K criteria the electrode sites are 
 Two mastoid/aural (A1, A2) 
 Two central (C3, C4)  
 Two occipital (O1, O2)  
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Ideal electrical settings are 
Electrode impedance Less than 500 ohms 
Standard gain Deflection of 1cm for every 50μv 
EEG deviations C4-A1, O2-A1 
Electrode for backup C3-A2 
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ELECTRODE PLACEMENT 
Done according to the International 10-20 system 
 
 
Figure 9 Steps for placement of electrodes 
 
The four landmark locations are-nasion, inion, left preauricular region, and right 
preauricular region. 
Steps to be followed for placement of electrodes are as below. 
1. The distance between nasion and inion is measured. 
2. Fpz is marked at 10% of this total distance from nasion. 
3. Oz is marked at 10% of this total distance from inion. 
4. Cz is marked at halfway between nasion and inion. 
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5. Fpz ,Oz and Cz are along the line joining nasion and inion. 
6. Fz is marked at 20% of distance from Cz in the front. 
7. Pz is marked at 20% of distance from Cz in the back. 
8. Distance between left and right preauricular point was measured (passing 
through Cz). 
9. C3 is marked at 20% distance from Cz on the left. 
10. C4 is marked at 20% distance from Cz on the right. 
11. T3 is marked at 10% the interauricular distance from the left mastoid 
12. T4 is marked at 10% the interauricular distance from the right mastoid. 
13. Head circumference is measured through all the 10% points (50% of which 
coincides with Fpz& Oz in the front and back respectively). 
14. O1 is 5% of the circumference to the left of Oz. 
15. O2 is 5% of the circumference to the right of Oz. 
16. Fp1 is 5% of the circumference to the left of Fpz. 
17. Fp2 is 5% of the circumference to the right of Fpz. 
18. C3 is 50% of the distance from Fp1to O1 on the interauricular line. 
19. F3 is 25% of this distance in the front. 
20. P3 is 25% of this distance in the back. 
21. C4, F4 & P4 are corresponding points in the right. 
22. T5 & T6 are 10% distance of circumference from O1 & O2 in the left & 
right side respectively. 
23. F7 &F8  are 10% distance of circumference from Fp1 & Fp2 in the left & 
right side respectively. 
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24. A1 and A2 are placed on the left and right mastoid processes. 
 
 Electrodes are placed in the above mentioned positions. Conventionally the 
alphabets denote the Frontal, occipital, parietal, temporal ,auricular and central 
regions. 
 
 Odd numbers are used to denote left sided electrodes and even numbers are 
used for the right side. 
.  
Figure 10:10 -20 System of electrode placement for EEG 
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Electro oculogram: 
 Records the potential difference between the retina and cornea. 
 The electrodes for recording are are placed as follows. 
 E1-1cm out and below the outer canthus of the left eye. 
 E2- 1 cm out and above the outer canthus of right eye. 
 Reference electrode is A2. 
 
Electromyogram  
 Recorded in the chin and leg. 
 Chin EMG needs two electrodes placed 2 cm below the chin; 2 cm right 
and left of the midline. 
 Limb movement is recorded through EMG of anterior tibialis muscle by 
placing electrodes in the outer aspect of lower half of each leg. 
 
Sensors: 
 Sensors are used to measure airflow, oxygen saturation and snoring. 
 
 Non invasive finger probe is used to record the percentage hemoglobin 
saturated with oxygen. 
 Airflow is measured through nasal prongs. A pressure transducer 
connected to the prongs record the pressure on the prongs created due to 
flow of air and thus gives an indirect measure of airflow. 
 Effort of respiration is measured through expansible belts placed around 
thorax and abdomen. 
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 The impedance and signals of all electrodes were checked after placing the 
electrodes and sensors. 
 Biocalibration of the physiological parameters were done at the beginning 
and end of the procedure. Steps of calibration are 
 Close eyes for 30 seconds to reveal α- activity. 
 Open eyes for 30 seconds to eliminate α- activity. 
 Subjects were instructed to hold head still in midline and move eyes to 
right and left to mimic REM sleep. 
 With head held still in midline ask the subject to move eyes up and down 
to differentiate horizontal and vertical eye movements. 
 Holding a deep breath for 5-10 seconds mimics central apnoea. Moving the 
chest and abdomen in and out while still breath holding mimics obstructive 
apneoa. 
 Movement of feet are also calibrated. 
 
Documentation of the procedure 
 Apart from the recording the observer should document the duration of the 
study procedure, methods of calibration, complaints from the patient , other 
technical difficulties and measures taken to correct them. 
 
 On completion of the recording the data collected should be saved properly 
and the electrodes and sensors should be cleaned and sterilized. 
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Analysis of the data and Scoring  
Events to be analysed and scored are 
 Stages of sleep 
 Arousal  
 Cardiac events 
 Respiratory events 
 Movements 
 
SCORING BY EPOCHS 
 The polygraphic record is analysed in segments called epochs. Each epoch 
is of 300 mm length and 30 seconds duration. 
 
 Each epoch should represent a sleep stage. When more than one stage is 
present in an epoch the score is determined according to the stage that occupies 
greater portion of the epoch.  
 
SCORING OF SLEEP STAGES  
Awake stage 
The epoch consists of >50% of α EEG waves over theoccipital region when 
eyes closed. If α waves are absent look for one of the following 
 Eye blinks (0.5-2Hz) 
 Slow conjugate eye movement followed by a rapid movement in the 
opposite direction, 
 Rapid open eye movements associated with normal or high chintone. 
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Figure 11 Epoch of stage awake and stage 1 
 
Stage-I-  
 More than 50% of the epoch is occupied by low amplitude waves of 
frequencies between 4 to 7 Hz . 
 
 If α waves were absent in the awake stage the epoch would show Vertex 
sharp waves of <0.5 seconds duration maximally over the central region and Slow 
rolling eye movement. 
 
Stage II- 
 The epoch consists of K complexes. 
 
 As  spindles also accompany the K complexes spindles are pathognomonic 
of this stage. 
 
 Except for the eye movement other findings of stage I is also present. 
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Stage III and IV – 
More than 20%of the epoch shows slow waves of 0.5-2Hz and >75uV amplitude. 
 
Figure 12 Epoch of Non-REM SLEEP 
 
REM  
Epoch would be occupied by waves of  low amplitude and mixed frequency.  
EOG shows rapid eye movement. 
EMG records a reduced tone. 
 
Figure 13 Epoch of REM SLEEP 
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SCORING RULES FOR RESPIRATORY EVENTS: 
 More than 90% decrease in amplitude of airflow for atleast 10 seconds is 
scored as Apnoea. 
 
 If this period of apnoea is accompanied by inspiratory effort it is of 
obstructive type. 
 
 If no inspiratory effort is present during this period it is of central type. 
 
 Absence of inspiratory effort in the initial period and few efforts in the later 
part denotes a mixed type. 
 
 If airflow amplitude decreases by more than 30% of the normal for atleast 
10 seconds along with greater than 4% decrease in oxygen saturation it is scored 
as hypoapnoea. 
 
Arousal: 
 Shift in the frequency in an abrupt fashion lasting for > 3 seconds preceded 
by 10 seconds of stable sleep during NREM sleep is scored as arousal. 
 
 This abrupt frequency shift is accompanied by increase in chin EMG for > 
1 second if arousal occurs in REM sleep. 
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Respiratory Effort Related Arousal (RERA)-  
 Flattening of airflow wave for > 10 seconds but not meeting the criteria for 
apnoea or hypoapnoea precedes arousal. Sometimes there is heightening of effort 
of respiration. 
 
Periodic limb movement in sleep 
 Increase in the amplitude of EMG wave 8μV above the baseline lasting 0.5 
to 10 seconds duration  consecutively for four times with a gap of 5 to 90 seconds 
between onset of two movements. If onset of movement on different legs are 
separated only by < 5 seconds it is considered as single movement.  
 
DEFINITION OF SLEEP ARCHITECHTURE  
Sleep Onset The first three consecutive Epochs of Stage I sleep 
Latency to REM The period of time from sleep onset to first Epoch of REM 
NAP onset (Sleep) 
latency the period of time to lights out to sleep onset 
Sleep Period Time 
(SPT) The time from sleep onset to last Epoch of sleep 
Total Recording Time 
(TRT) The time from lights out to lights on 
Total Sleep Time 
(TST) The amount of sleep recorded during TRT 
Wakefulness After 
Sleep Onset (WASO) 
The Wakefulness occurring from sleep onset to last 
Epoch of sleep 
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 FORMULAE FOR SCORING 
% Stage I Minutes of Stage I *100/ Total SleepTime (TST) 
% Stage II Minutes of Stage II *100/ Total Sleep Time(TST) 
% Stage III & IV Minutes of Stage III&IV *100/ Total Sleep Time(TST) 
% Stage R Minutes of Stage R *100/ Total Sleep Time(TST) 
% Wake time Minutes of Wake *100/ Sleep Period Time (SPT) 
 
 
OTHER INDICES 
Apnoea Hypoapnoea 
Index (AHI) 
Total number of apnoeas and Hypoapnoeas 
occurring per hour of sleep 
Respiratory 
Disturbances Index 
(RDI) 
Total number of apnoeas and Hypoapnoeas and 
Respiratory Effort Related Arousals 
occurring per hour of sleep 
Desaturation Index 
Total number of desaturation events per hour of 
sleep 
 
Subjective Measurement of Sleep 
 Clinical evaluation of sleep quality in the study participants was done using 
self reported questionnaires. The instruments used were  
 Pittsburgh Sleep Quality Index (PSQI) 
 Epworth Sleepiness Scale (ESS) 
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Pittsburgh Sleep Quality Index (PSQI) 
 Measure the sleep quality over the past one month. It is 19 item scale 
which is self reported and consists of an additional 5 items rated by the bed 
partner but not used for scoring. It is a Likert type that scores seven domains  
 
1. subjective sleep efficiency  
2. sleep latency  
3. sleep duration  
4. sleep quality  
5. sleep disturbance  
6. sleep medication use  
7. daytime dysfunction due to sleepiness 
 
 Total score range is 0 to 21. A score of > 5 denotes poor quality of sleep. 
Higher the score poorer the sleep. With this cut off score of 5 the sensitivity and 
specificity of PSQI in identifying sleep disorders is 89.6% and 86.5%. it is 
available in 48 languages across the world and is the widely used scale in large 
population based studies. 
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Epworth Sleepiness Scale (ESS): 
It is an 8 item self reported scale. It measures the excessive daytime sleepiness. It 
is also a Likert scale. Each subscale has scores from 0-3. The respondent has to 
indicate the chances of “ doze-off or fall asleep “ in eight different real life 
situations. 
1. Sitting reading 
2. Watching TV  
3. Inactive in public 
4. Car passenger 
5. Lying down 
6. Sitting talking 
7. Sitting quietly  
8. Car in traffic 
Total score range is from 0 – 24. Higher the score higher is the likelihood of 
daytime sleepiness. 
A cutoff score of 10 is taken for indicating excessive sleepiness during the day 
which is an indirect measure of poor sleep during the night. Higher scores of ESS 
have been consientantly associated with PSG findings in OSAS, narcolepsy etc. it 
is also one of the widely used scales in 52 languages across the world. 
  
Results 
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RESULTS 
 
 The data obtained from the above said methods were statistically analysed 
using SPSS software version 17 statistical significance of the data collected were 
analysed using UNPAIRED T TEST. 
 
 The relationship between individual parameters were analysed by 
Pearson’s  rank correlation and Spearman rho’s correlation. 
 
Table I :  Baseline Parameters 
PARAMETER MEAN SD 
AGE 50.83 ± 5.38 
BMI 27.1 ± 2.99 
FBS 154.73 ±16.15 
PPBS 237.93 ± 31.69 
 
In total 30 patients participated in the study. Out of which 16 are males and 
14 are females. The mean age of the participants was 50.83 ± 5.38 with mean 
value of BMI 27.1 ± 2.99.  The mean value of FBS was 154.73 ± 16.15. and 
PPBS was 237.93 ± 31.69. 
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 The mean and standard deviation of the collected data that was included for 
analysis is as shown in the following table : 
 
Table II: mean and standard deviation of study parameters 
S.NO PARAMETER 
MEAN±S.D 
( CASES ) ( CONTROL ) 
1. N1 (mins) NREM SLEEP 25.93 ± 4.06 18.30 ± 1.83 
2. N2 (mins) NREM SLEEP 141.80 ± 11.04 152.67 ± 9.40 
3. N3 (mins) NREM SLEEP 47.00 ± 10.81 52.23 ± 5.47 
4. REM (mins) SLEEP 64.53 ± 8.01 68.83 ± 4.74 
5. Total sleep time 279.70 ± 26.23 292.03 ± 18.18 
6. Sleep efficiency 74.30 ± 7.11 77.65 ± 3.95 
7. Sleep latency 33.00 ± 9.33 26.80 ± 3.95 
8 Diabetes duration 7.73 ± 4.04 - 
9. HbA1c 7.94 ± 0.98 4.72 ± 0.53 
10. PSQI 7.90 ± 3.06 5.37 ± 1.12 
11. ESS 11.90 ± 4.06 9.07 ± 1.79 
 
 
 The above parameters were taken for analysis statistically. The correlation 
of HbA1c and diabetes duration with various sleep parameters have been 
calculated by PEARSON’S method. 
  
63 
 
 
TABLE III: Comparison of sleep stages between study group and control group 
 GROUPING N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
t DF p Value 
N1(mins) 
STUDY 
GROUP 30 25.93 4.068 .743 
9.315 41.038 0.000* 
CONTROL 
GROUP 30 18.30 1.896 .346 
N2(mins) 
STUDY 
GROUP 30 141.80 11.043 2.016 
-4.103 58 0.000* 
CONTROL 
GROUP 30 152.67 9.404 1.717 
N3(mins) 
STUDY 
GROUP 30 47.20 10.810 1.974 
-2.275 42.961 0.028* 
CONTROL 
GROUP 30 52.23 5.475 1.000 
REM(mins) 
STUDY 
GROUP 30 64.53 8.016 1.464 
-2.529 47.084 0.015* 
CONTROL 
GROUP 30 68.83 4.742 .866 
*p Value Significant at the level <0.05 
 
 The sleep stages N2 , N3 and REM of study group shows a significant 
decrease when compared to control group and N1 sleep stage shows a significant 
increase when compared to control group. (*p-value <0.05) 
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Graph 1 Shows N1 stage of sleep in mins: the mean value of study group 
(25.93) is higher than that of controls (18.30). 
 
 
Graph 2 Shows N2 stage of sleep in mins: the mean value of study group 
(141.80 ) is lower than that of control group (152.67). 
  
25.93
18.30
.00
5.00
10.00
15.00
20.00
25.00
30.00
STUDY GROUP CONTROL GROUP
COMPARISON OF N1 SLEEP BETWEEN STUDY GROUP AND 
CONTROL GROUP 
STUDY GROUP
CONTROL GROUP
141.80
152.67
136.00
138.00
140.00
142.00
144.00
146.00
148.00
150.00
152.00
154.00
STUDY GROUP CONTROL GROUP
COMPARISON OF N2 SLEEP BETWEEN STUDY GROUP AND 
CONTROL GROUP
STUDY GROUP
CONTROL GROUP
65 
 
 
 
Graph 3 Shows N3 stage of sleep in mins: the mean value of study group 
(47.20 ) is lower than that of control group (52.23). 
 
 
Graph 4 Shows REM stage of sleep in mins: the mean value of study group 
(64.53) is lower than that of control group (68.83). 
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TABLE:IV Comparison of percentages of various stages of sleep between study 
group and control group 
 GROUPING N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
T DF p Value 
N1% 
STUDY 
GROUP 30 9.383 2.0707 .3780 
7.562 37.548 0.000* 
CONTROL 
GROUP 30 6.317 .8039 .1468 
N2% 
STUDY 
GROUP 30 50.873 1.7426 .3181 
-3.949 43.096 0.000* 
CONTROL 
GROUP 30 52.283 .8875 .1620 
N3% 
STUDY 
GROUP 30 16.697 2.6558 .4849 
-2.255 35.461 0.030* 
CONTROL 
GROUP 30 17.850 .8920 .1629 
REM% 
STUDY 
GROUP 30 23.047 1.1362 .2074 
-2.077 47.693 0.043* 
CONTROL 
GROUP 30 23.550 .6867 .1254 
*p Value Significant at the level <0.05 
 
 The N2 % , N3%  and REM % of study group shows a significant decrease  
when compared to control group and N1%  shows a significant increase when 
compared to control group (p<0.05).  
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Graph 5 Shows N1% of sleep : the mean value of study group (9.383) is 
higher than that of control group (6.317). 
 
 
Graph 6 Shows N2% of sleep : the mean value of study group (50.873) is 
lower than that of control group (52.283). 
 
 
9.383
6.317
.000
2.000
4.000
6.000
8.000
10.000
STUDY GROUP CONTROL GROUP
COMPARISON OF N1% BETWEEN STUDY GROUP AND 
CONTROL GROUP
STUDY GROUP
CONTROL GROUP
52.283
50.000
50.500
51.000
51.500
52.000
52.500
STUDY GROUP CONTROL GROUP
COMPARISON OF N2% BETWEEN STUDY GROUP AND 
CONTROL GROUP
STUDY GROUP
CONTROL GROUP
68 
 
 
 
 
Graph 7 Shows N3% of sleep : the mean value of study group (16.697) is 
lower than that of control group (17.850).  
 
 
 
Graph 8  Shows REM% of sleep : the mean value of study group (23.047) is 
lower than that of control group (23.550).  
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TABLE:V Comparison of Total sleep time, Sleep efficiency % and sleep latency 
between study group and control group 
 GROUPING N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
t DF p Value 
Total sleep 
time(mins) 
STUDY 
GROUP 30 279.70 26.233 4.789 
-2.116 51.647 0.039* 
CONTROL 
GROUP 30 292.03 18.188 3.321 
sleep 
efficency 
% 
STUDY 
GROUP 30 74.300 7.1155 1.2991 
-2.255 45.326 0.029* 
CONTROL 
GROUP 30 77.650 3.9504 .7212 
Sleep 
latency 
(mins) 
STUDY 
GROUP 30 33.00 9.337 1.705 
3.350 39.066 0.001* 
CONTROL 
GROUP 30 26.80 3.951 .721 
*p Value Significant at the level <0.05 
 
 The Total sleep time (TST) , sleep efficiency %  of study group shows a 
significant decrease   when compared to control  group  and sleep latency  of 
study group shows significant increase when compared to control group.(*p-value 
< 0.05)  
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Graph 9 Shows Total sleep time in mins: the mean value of study group 
(279.70) is lower than that of control group (292.03) 
 
 
Graph 10 Shows sleep efficiency %: the mean value of study group (74.300) is 
lower than that of control group (77.650) 
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Graph 11Shows  Total sleep latency in  mins. the mean value of study group 
(33.00) is higher  than that of control group (26.80) 
 
TABLE:VICOMPARISON OF SUBJECTIVE SLEEP SCORES  
BETWEEN STUDY GROUP AND CONTROL GROUP 
 GROUPING N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
T DF p Value 
PSQI 
STUDY 
GROUP 30 7.90 3.067 .560 
4.246 36.720 0.000* 
CONTROL 
GROUP 30 5.37 1.129 .206 
ESS 
STUDY 
GROUP 30 11.90 4.063 .742 
3.493 39.952 0.001* 
CONTROL 
GROUP 30 9.07 1.799 .328 
*p Value Significant at the level <0.05 
 
 The PSQI and ESS of study group shows a significant increase (*p-value ) 
when compared to control group . 
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Graph 12  Shows  Pittsburgh sleep quality index: the mean value of study 
group (7.90) is higher than that of control group (5.37) 
  
 
 
Graph 13  Shows  Epworth sleepiness scale: the mean value of study group 
(11.90) is higher than that of control group (9.07). 
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TABLE:VII Correlation OF HbA1c and sleep pattern in study group 
 
Total sleep time 
(mins) 
Sleep efficiency 
% 
Sleep latency 
(mins) 
HbA1C 
Pearson 
Correlation -.923
** -.974** .936** 
Sig. 
(2-tailed) .000 .000 .000 
N 30 30 30 
  
Negative 
correlation 
Negative 
correlation 
Positive 
correlation 
 
 Correlation table of HbA1c with total sleep time, sleep efficiency and sleep 
latency.Total sleep time(r=-0.923) and sleep efficiency(r=-0.974) shows negative 
correlation whereas  sleep latency (r=0.936) shows positive correlation. The 
correlation was highly significant with P<0.05 for all three parameters. 
 
TABLE: VIII Correlation of  Diabetes duration and sleep pattern in study group 
  
Total sleep time 
(mins) 
Sleep efficiency 
% 
Sleep latency 
(mins) 
Diabetes 
duration 
(Years) 
Pearson 
Correlation -.926
** -.991** .929** 
Sig. (2-
tailed) .000 .000 .000 
N 30 30 30 
  
Negative 
correlation 
Negative 
correlation Positive correlation 
 
 Correlation table of Diabetes duration with total sleep time, sleep 
efficiency and sleep latency. Total sleep time(r=-0.926) and sleep efficiency(r=-
0.991) shows negative correlation whereas  sleep latency (r=0.929) shows positive 
correlation. The correlation was highly significant with P<0.05 for all three 
parameters. 
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Graph 14 Scatter plotgraph shows correlation of HbA1c  and sleep pattern in 
study group 
  
75 
 
 
 
 
 
 
 
 
Graph 15 Scatter plotgraph shows correlation of Diabetes duration   and 
sleep pattern in study group 
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The analysed results of this study could be summarized as follows. 
 The Total Sleep Time (mins) and Sleep efficiency(%) shows a significant 
decrease in the diabetic patients when compared to the controls. 
 With regards to the sleep architecture there is a significant decrease in 
duration of  N2 & N3 stages of non REM sleep(in mins) along with 
decrease in REM sleep duration in the diabetic group when compared to 
the control group. 
 But there is a significant increase in N1 stage of non REM sleep in the 
study group in comparison with the controls. 
 The diabetic group shows a significant increase in sleep latency when 
compared with the controls. 
 The subjective sleep assessment scores of PSQI and ESS are significantly 
lower in diabetics than the controls. 
 As the duration of diabetes increases there is a decrease in duration and 
quality of sleep evidenced by decrease in total sleep time  and sleep 
efficiency and increase in sleep latency. 
  When  there is an increase in HbA1c there is a decrease in duration of 
sleep and sleep efficiency and increase in sleep latency. 
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DISCUSSION 
 
 Maria Pallayova et al (72) analysed polysomnographic recordings of 22 
diabetics and 22 non diabetics and found that there was a significant decrease in 
Slow Wave Sleep (SWS)duration in diabetics compared to normals. The authors 
have concluded that changes in sleep architecture could be used to predict 
diabetes at an early stage. In this present study also the duration of  SWS is 
decreased in the diabetic group than the normal group. 
 
 Dorit Koren et al (73) have done a study on 62 obese adolescents by 
measuring the HbA1c, oral glucose tolerance test, serial insulin and glucose levels 
along with a overnight polysomnography. The authors found a U shaped 
association between SWS with both HbA1c and glucose levels. There was also a 
positive association between duration of SWS and insulin secretary measures. 
Thus the authors concluded that both insufficient and excessive sleep resulted in 
hyperglycemia. Decreased N3 was associated with insufficient insulin secretion. 
The present study also replicates the same findings like decreased duration of N2 
and N3 stages. Also there was a significant association of HbA1c with duration 
and quality of sleep. 
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EsraTasali et al (74)did a study on 9 healthy young non obese individuals 
to establish the association between sleep architecture and insulin measures. They 
experimentally suppressed the SWS by using auditory stimuli without disturbing 
the total duration of sleep. The results showed a marked decrease in insulin 
sensitivity without any compensatory increase in insulin secretion denoting 
decreased glucose tolerance that shows an increased risk of diabetes. 
 
 Toshia ki Ohkuma et al (75) examined the associations of sleep duration and 
HbA1c levels in 4870 type 2 diabetes patients. They classified the participants 
according to the duration of sleep vizless than 4.5 h, 4.5–5.4 h, 5.5–6.4 h, 6.5–7.4 
h, 7.5–8.4 h, and more than 8.5 h which was self reported. There was a quadratic 
association of sleep duration with HbA1c with 6.5-7 hr. being the normal 
comaparator. Both longer and shorter duration of sleep  were associated with 
higher HbA1c. our study also shows that shorter the duration of sleep higher the 
HbA1c. 
 
 Singh et al (76) had  done a detailed  polysomnographic study on 33 diabetic 
patients in the age group of 40-80 yrs.  they found an association with presence of 
various degrees of OSA in these subjects reflecting a poor quality of sleep. The 
sleep study parameters showed a decrease in sleep efficiency to approximately 
52%. The present study also shows decrease in sleep efficiency with a mean of  
74.30 ± 7.11(normal should be atleast 85%). This sleep efficiency is also 
negatively correlating with HbA1c levels.  
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 Upneet et al(77) studied the quality of sleep and daytime sleepiness in 201 
type 2 diabetes patients using PSQI and ESS. They found that around 35% of the 
study population were reporting daytime sleepiness as evidenced by the ESS 
score. Consistently the PSQI scores were higher in these patients. This reflects the 
poor quality of sleep in diabetes patients. In our present study also the scores of 
PSQI and ESS are higher in the diabetics than the controls. 
 
 Bixler et al (78) did a biphasic cohort study on the general population of 
about 16583 subjects randomly selected through the telephonic register in 
Pennsylvania. Out of this large cohort 1741subjects with excessive daytime 
sleepiness were identified and subjected to sleep study in the laboratory ,screened  
for diabetes, obesity, depression. The authors found a strong association of 
excessive daytime sleepiness with BMI and Diabetes pointing to the proposal that 
metabolic syndrome is an important cause for poor sleep quality. In this present 
study also the scores of ESS are higher in diabetic group than the controls 
suggesting that diabetes may be a cause for excessive daytime sleepiness. 
 
 Bing-Qian Zhu et al (79)  investigated the impact of sleep quality on 
glycemic control in 220 type 2 diabetes patients. Using the PSQI they assessed the 
quality of sleep and measured HbA1c to assess glycemic control. They found that 
sleep problems like sleep latency, sleep disturbance and daytime sleepiness were 
strongly associated with poor glycemic control (HbA1c≥7%). Our study also have 
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shown that increase in HbA1c is significantly correlated with increase in sleep 
latency and ESS scores. 
 
Gislason T et al (80)did an epidemiological study on 3201 swedish men to 
investigate effects of somatic diseases on the sleep quality and pattern. The 
authors studied effect of COPD, Rheumatic disease, obesity, hypertension and 
diabetes on sleep. All subgroups had sleep complaints. Among them the diabetic 
group had problems like Difficulty Initiating Sleep, 
 
 Difficulty Maintaining sleep and Excessive Daytime Sleepiness. This is in 
favour of the results obtained from the present study. 
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CONCLUSION 
From the above discussions the following conclusions could be derived from the 
present study. 
 Type 2 diabetes patients have problems in sleep quality . 
 The Total sleep time  is decreased than normal controls denoting a 
reduction in sleep duration in diabetics. 
 There is a reduction in Slow wave sleep which denotes that the sleep is not 
restorative and refreshing in these subjects. 
 There is an increase in sleep latency and decrease in sleep efficiency that 
denotes that diabetics have difficulty in both initiation and maintenance of 
sleep. 
 The above findings in polysomnography are supported by the scores of 
Pittsburgh sleep quality index (PSQI)  and Epworth sleepiness scale (ESS). 
 These changes  identified in the sleep study could lead to poor glycemic 
control in type 2 diabetes patients. 
Thus patients reporting with sleep difficulties should be screened for diabetes. 
Type 2 diabetes patients with poor glycemic control should be assessed for 
sleep disorders and if present it should be corrected to achieve optimum 
control of blood sugar levels. 
 
LIMITATION OF THE STUDY : 
 However, the study has got its own limitations as the above findings need 
to be confirmed with a larger sample size. 
Summary 
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SUMMARY 
 
 A study was conducted on thirty type 2 diabetes patients against thirty 
matches non diabetic controls. The parameters studied were overnight 
Polysomnography, glycated hemoglobin ( HbA1c), Pittsburgh sleep quality index 
(PSQI) Epworth  sleepiness scale (ESS). The results when statistically analysed 
showed a poor quality of sleep in diabetic patients than controls as there was 
increased sleep latency, decrease in Total sleep Time with particular reduction in 
the N2 and N3 phases and decrease in sleep efficiency in the diabetic group than 
controls. These findings are  supported by scores of PSQI and ESS. Also there 
was a significant association of the sleep abnormalities with glycemic control and 
duration of diabetes. This  indicates  patients with diabetes should be screened for 
sleep problems .The correction of  these problems can help the diabetes patients 
for the better control of  hyperglycemic conditions. 
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Annexures 

INFORMED CONSENT FORM 
 
Title of the study: A Study of sleep pattern in type 2 diabetes patients and  its  correlation 
with HbA1c 
 
Name of the Participant   :  
 
Name of the Principal Investigator : Dr.V.SARAVANAN 
 
Name of the Institution   :  
 
Institute of Physiology and Experimental Medicine, 
          Madras Medical College and Govt. General Hospital, 
          Chennai – 3 
 
Documentation of the informed consent 
I _____________________________ have read the information in this form (or it has 
been read to me). I was free to ask any questions and they have been answered. I am over 
18 years of age and, exercising my free power of choice, hereby give my consent to be 
included as a participant in 
 
A study of sleep pattern in type 2 diabetes patients correlation and its with 
HbA1c 
 
1. I have read and understood this consent form and the information provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator. 
5. I have been informed the investigator of all the treatments I am taking or have taken in 
the past ________ months including any native (alternative) treatment. 
6. I have been advised about the risks associated with my participation in this study. 
7. I agree to cooperate with the investigator and I will inform him/her immediately if I 
suffer unusual symptoms.  
8. I have not participated in any research study within the past _________month(s).  
9. I am aware of the fact that I can opt out of the study at any time without having to give 
any reason and this will not affect my future treatment in this hospital.  
10. I am also aware that the investigator may terminate my participation in the study at 
any time, for any reason, without my consent.  
12. I hereby give permission to the investigators to release the information obtained from 
me as result of participation in this study to the sponsors, regulatory authorities, 
Govt. agencies, and IEC. I understand that they are publicly presented. 
13. I have understand that my identity will be kept confidential if my data are publicly 
presented. 
14. I have had my questions answered to my satisfaction. 
15. I have decided to be in the research study. 
 
I am aware that if I have any question during this study, I should contact the investigator. 
By signing this consent form I attest that the information given in this document has been 
clearly explained to me and understood by me, I will be given a copy of this consent 
document. 
 
 
For adult participants: 
 
Name and signature / thumb impression of the participant (or legal 
representative if participant incompetent) 
 
Name _____________________ Signature_______________ Date________ 
 
 
Name and Signature of impartial witness (required for illiterate patients): 
 
Name _____________________ Signature_______________ Date________ 
 
Address and contact number of the impartial witness: 
 
Name and Signature of the investigator or his representative obtaining consent: 
 
Name _____________________ Signature_______________ Date________ 
 
PROFORMA 
1. Name     : 
2. Age    : 
3. Sex    : 
4. Address     : 
5. Occupation    : 
6. Complaints/duration  : 
7.  History of present illness : 
8. History of day time somnolence: 
9. History of snoring from partner: 
10. Past history   : 
11. History of any drug intake :Sleep medications,Anti anxietydrugs,Anti 
psych iatric drugs 
12. History of sweating : 
13. History of night terrors: 
11.History of associated illness: 
a. Peripheral neuropathy 
b. Hypertension 
c. Ischemic heart disease 
d. Respiratory diseases 
e. Renal diseases 
f. Hypothyroidism 
INVESTIGATIONS : 
 
Serum HbA1c levels, Fasting blood sugar, Post prandial sugar,  
 
EXAMINATION : 
 
General examination: 
Temperature  : 
Pulse rate   : 
Blood pressure  : 
Body mass index  :  
 
Systemic examination: 
 
Cardiovascular system : 
Respiratory system :  
 
Gastrointestinal system : 
 
Central nervous system : 
  
  
   
   
  
POLYSOMNOGRAPHY REPORT 
Patient Name: Shankar   
Sex: M Study Date: 31-01-2017 
D.O.B. 01-06-1959 Study Type:  DIAGNOSTIC 
Age: 57 years   
Height: 162.0 cm Referring Physician: Prof.Dr. P.Dharmarajan 
Weight: 82.0 kgs Interpreting Physician: Dr. V.Saravanan 
B.M.I: 31.2 kg/m2   
 
SLEEP ARCHITECTURE  
Lights off clock time:   22:48:13 
Lights on clock time:  05:14:13 
   Total Recording Time (TRT):  386 minutes 
Time In Bed (TIB):  386 minutes 
Total Sleep Time (TST):  232.0 minutes 
Sleep Efficiency:                                                                                62 % 
   Sleep Latency:                                                                            50.0 minutes 
 
Sleep Staging Duration % TST 
N 1: 32.0 minutes 14.0 % 
N 2: 122.0 minutes 52.5% 
N 3: 23.0 minutes 10.0% 
R: 55.0 minutes 23.5 % 
 
 
39.9
14.28.3
31.6
6.0
WK
REM
N1
N2
N3
S. 
No.
age 
(Years)
sex BMI
 N1 
(mins)
N2 
(mins)
N3 
(mins)
REM 
(mins)
N1% N2% N3%
REM
%
TST 
(mins)
sleep 
efficency 
%
Sleep 
latency 
(mins)
Diabetes 
duration 
(Years)
FBS 
(mg/dl)
PPBS 
(mg/dl)
HbA1C PSQI ESS
1 41 m 18.6 27 167 57 77 8 51 17.5 23.5 328 84 23 3 136 208 6.9 4 7
2 57 m 31.2 32 124 24 52 14 53.5 10 22.5 232 62 50 15 192 324 10 13 18
3 46 f 29 24 147 54 73 8 49.5 18 24.5 298 80 26 5 142 210 7.2 5 7
4 45 f 25.7 28 150 50 67 9.5 51 17 22.5 295 82 24 3 136 210 6.9 4 7
5 60 f 29.7 28 120 26 52 12.5 53 11.5 23 233 60 52 16 180 310 10.2 14 18
6 46 m 23.7 25 144 54 70 8.5 49 18.5 24 293 81.5 30 3 136 202 7 5 8
7 60 f 28.1 17 129 42 58 7 52.5 17 23.5 246 69.5 42 10 164 260 8.6 11 16
8 52 f 26.1 20 134 53 67 7 49 19.5 24.5 274 73 32 8 152 230 7.8 8 12
9 52 f 27.3 29 138 31 53 11.5 55 12.5 21 251 66 46 13 172 270 9.2 12 18
10 57 f 28.5 21 126 44 61 8.5 50 17.5 24 252 69.5 40 11 186 286 8.6 10 15
11 42 m 27.6 24 156 60 76 7.5 49.5 19 24 316 81 21 4 140 210 7 5 7
12 53 m 25.7 26 135 46 62 9.5 50.5 17 23 269 72 36 8 158 246 7.9 8 13
13 45 f 29.4 23 157 61 70 7.5 50.5 19.5 22.5 311 85 20 2 132 206 6.8 3 6
14 58 m 31.3 34 128 32 54 13.5 51.5 13 22 248 66 44 13 168 252 9.1 11 18
15 49 m 24.8 23 148 51 68 8 51 17.5 23.5 290 80 22 5 140 208 7.1 5 8
16 50 f 28.1 29 155 52 68 9.5 51 17 22.5 304 80 24 4 146 212 7.1 5 8
17 50 f 28.1 30 144 37 54 11.5 54 14 20.5 265 68 42 12 162 236 9 11 16
18 58 m 25.4 27 137 48 65 9.5 49.5 17.5 23.5 277 71.5 38 9 168 270 8.1 9 13
19 56 f 28.2 25 134 45 63 9.5 50 17 23.5 267 70 28 10 160 256 8.4 10 14
20 51 f 26.4 24 148 59 71 8 49 19.5 23.5 302 77.5 26 6 150 224 7.5 7 11
21 45 m 27.3 27 137 40 55 10.5 53 15.4 21.1 259 72 36 8 142 220 8 9 13
22 43 m 23.1 24 156 61 74 7.5 49.5 19.5 23.5 315 87.5 22 1 130 202 6.6 3 6
23 46 m 24.1 22 147 61 74 7 48.5 20 24.5 304 79.5 26 5 146 216 7.3 6 9
24 55 m 27.7 23 132 44 61 9 50.5 17 23.5 260 71 28 9 160 250 8.2 9 14
25 48 m 31.2 34 139 41 59 12.5 51 15 21.5 273 70 40 10 150 224 8.4 10 14
26 53 m 21 27 144 50 64 9.5 50.5 17.5 22.5 285 75 34 7 154 232 7.5 7 12
27 54 f 31.1 33 135 30 53 13 53.7 12 21.3 251 64 48 14 178 268 9.6 12 18
28 53 m 26.7 22 147 54 67 7.5 51 18.5 23 290 74 32 7 156 240 7.6 8 12
29 50 m 29 25 147 60 75 8 48 19.5 24.5 307 79.5 30 5 150 220 7.2 6 9
30 50 f 29.7 25 149 49 73 8.5 50.5 16.5 24.5 296 78 28 6 156 236 7.4 7 10
MASTER CHART - CASES ( TYPE II DIABETES )
S. 
No.
age 
(Years)
sex BMI
 N1 
(mins)
N2 
(mins)
N3 
(mins)
REM 
(mins)
N1% N2% N3% REM%
TST 
(mins)
sleep 
efficency 
%
Sleep 
latency 
(mins)
FBS 
(mg/dl)
PPBS 
(mg/dl)
HbA1C PSQI ESS
1 52 m 28.4 19 151 48 67 6.5 53 17 23.5 285 78 26 100 162 5.1 6 10
2 49 m 27.3 20 161 55 76 6.5 51.5 17.5 24.5 312 80 28 82 146 4.2 4 6
3 42 f 31.2 15 177 67 75 4.5 53 20 22.5 334 88 20 78 146 4 4 6
4 47 m 30.8 19 154 50 70 6.5 52.5 17 24 293 78 28 96 160 4.5 5 9
5 50 f 30.4 16 148 48 62 6 54 17.5 22.5 274 76 28 96 164 4.8 6 10
6 44 m 28.3 19 164 59 78 6 51 18.5 24.5 320 82 22 84 148 4.1 4 7
7 54 f 33.7 18 138 49 65 6.5 51.5 18 24 270 75 32 98 164 5.1 6 10
8 56 m 26.9 22 153 49 65 7.5 53 17 22.5 289 74 31 102 172 5.4 6 11
9 50 f 30.3 15 155 53 71 5 53 18 24 294 78.5 25 90 162 4.5 5 8
10 44 m 29.1 19 163 55 73 6 52.5 18 23.5 310 81.5 24 86 150 4.1 4 7
11 41 f 30.5 17 174 65 79 5 52 19.5 23.5 335 86 18 72 142 3.8 4 7
12 54 m 27.6 18 141 44 60 7 53.5 17 22.5 263 73 32 102 168 5.2 6 10
13 47 f 30.8 20 160 51 71 6.5 53 17 23.5 302 78.5 29 94 156 4.5 5 10
14 56 m 28.3 21 149 46 64 7.5 53 16.5 23 280 72 27 104 170 5.3 7 11
15 49 f 28.3 17 153 50 68 6 53 17.5 23.5 288 79 29 90 152 4.4 5 9
16 46 m 28.3 18 146 51 66 6.5 52 18 23.5 281 76 32 98 160 4.8 6 11
17 58 f 32.9 16 141 46 66 6 52.5 17 24.5 269 71.5 26 104 176 5.4 8 12
18 54 m 29 21 144 50 70 7.5 50.5 17.5 24.5 285 73.5 30 102 168 5.3 6 10
19 49 f 31.2 20 158 55 71 6.5 52 18 23.5 304 79.5 27 94 154 4.4 5 9
20 52 m 28.3 19 149 49 69 6.5 52 17 24.5 286 74 31 100 162 5 6 10
21 55 m 27.3 20 144 48 62 7.5 52.5 17.5 22.5 274 76 30 104 182 5.5 5 9
22 50 f 32.9 20 145 53 69 7 50.5 18.5 24 287 77.5 25 96 156 4.6 6 10
23 50 m 31.2 18 155 56 71 6.5 51.5 18.5 23.5 300 78 25 90 160 4.6 6 9
24 45 m 29.8 17 163 60 74 5.5 52 19 23.5 314 80 23 86 148 4.2 4 6
25 48 f 27.4 16 147 56 69 5.5 51 19.5 24 288 79.5 24 84 154 4.3 5 9
26 59 m 29.7 20 145 45 61 7.5 53.5 16.5 22.5 271 71 32 106 186 5.6 8 13
27 44 m 29.7 15 156 55 69 5 53 18.5 23.5 295 82 20 80 150 4.2 4 7
28 47 f 31.7 19 153 52 67 6.5 52.5 18 23 291 79 22 82 146 4.1 4 7
29 52 m 28.7 17 151 54 69 6 52 18.5 23.5 291 77 27 102 166 5.2 5 9
30 55 f 30.3 18 142 48 68 6.5 51.5 17.5 24.5 276 75.5 31 106 180 5.4 6 10
MASTER CHART - CONTROL ( NON DIABETIC )
